SCHEMBL7658491

SCHEMBL7658491

O=c1[nH]c(N[C@H](CO)Cc2ccccc2)nc2[nH]cnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP3A4 P08684 6/20 0.42
IGF1R P08069 5/20 0.42
CYP1A2 P05177 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2C19 P33261 4/20 0.42
PARP1 P09874 1/20 0.41
PARP3 Q9Y6F1 1/20 0.41
MME P08473 2/20 0.41
JAK3 P52333 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
PNP P00491 2/20 0.39
EGFR P00533 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPK1 P28482 2/20 0.37
ROCK2 O75116 1/20 0.37
RPS6KA5 O75582 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2623142 0.76 HPGD (0.52) MEN1KMT2APNP
SCHEMBL27763565 0.76 KDM4E (0.43) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL27763566 0.76 KDM4E (0.43) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL7085340 0.75 ADORA2A (0.47) KDM4EMEN1MAPTKMT2AMME
SCHEMBL27564857 0.75 ADORA2A (0.47) KDM4EMEN1MAPTKMT2AMME
SCHEMBL2623146 0.75 ALDH1A1 (0.54) KDM4EMEN1KMT2ACYP1A2CYP2C9
Hydrochloric Acid SCHEMBL7088885 0.74 ADORA2A (0.47) KDM4EMEN1MAPTKMT2AMME
SCHEMBL27763562 0.74 KDM4E (0.42) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL1412351 0.73 KDM4E (0.40) KDM4EMEN1MAPTKMT2ACYP3A4
SCHEMBL27763561 0.72 CXCR2 (0.40) KDM4EMEN1MAPTKMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495528-B1 ANTIINFLAMMATORY AGENTS; INHIBITING LEUKOCYTE RECRUITMENT AND ACTIVATION; AGONISTS OF ADENOSINE 2A RECEPTOR SMITHKLINE BEECHAM CORPORATION 2002-12-17 US disclosed